Safety of a Herpes Simplex Candidate Vaccine (gD2t) With MPL and Its Efficacy to Prevent Genital Herpes Disease
Clinical trial NCT00699764 · COMPLETED
Trial details
- NCT number
- NCT00699764
- Sponsor
- GlaxoSmithKline
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1996-03-01
- Primary completion
- 1999-10-01
- Enrollment
- 2491
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.